Adverse side effects of hemodialysis in patients with end-stage chronic renal disease at Kassala Dialysis Center, Sudan
Main Article Content
Keywords
hemodialysis, complication, renal failure, Kassala
Abstract
Background: Hemodialysis is a treatment for advanced renal failure; however, various complications can arise following the procedure. Aim: This study aimed to investigate the incidence of adverse side effects during hemodialysis in patients with chronic renal failure. Methods: This descriptive hospital-based study was conducted on 105 patients treated with hemodialysis between November 2020 and January 2021 at the Kassala Dialysis Center in Kassala City, Kassala State, Sudan. Data were collected through interviews using a questionnaire designed to address the research questions. The data were analyzed using the software Statistical Package for the Social Sciences version 16. Results: The findings indicated that 61% of this study group were male and 39% were female. The disease duration ranged from 1 to 5 years in 56 patients (53.3%). The age group ranged from 10 to 80 years, with approximately half of the study population in the age groups of 31–40 and 41–50 years. Regarding educational level, the majority were illiterate, representing 45 patients (42.9%). The most common symptoms mentioned by patients included joint pain (56 patients, 53.3%), sleeping problems (34 patients, 32.4%), and muscle cramps (33 patients, 31.4%). The most frequently used medication for symptom relief was paracetamol (46 patients, 43.8%), followed by diclofenac sodium (14 patients, 13.3%). Conclusion: The most common adverse effects of hemodialysis are joint pain, sleeping problems, and muscle cramps. Addressing the adverse effect of hemodialysis could lead to comprehensive managing the patients with end-stage chronic renal disease ultimately improving the patient outcome and efficiency of health car delivery.
References
2. Wanek MR, Horn ET, Elapavaluru S, Baroody SC, Sokos G. Safe use of hemodialysis for dabigatran removal before cardiac surgery. Ann Pharmacother. 2012;46(9):e21. doi: 10.1345/aph.1R081.
3. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al . A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950-7. doi: 10.1038/ki.2015.230. .
4. Jha V, Chugh KS. Dialysis in developing countries: priorities and obstacles. Nephrology. 1996;2:65–71. doi:10.1111/j.1440-1797.1996.tb00068.x.
5. Van de Luijtgaarden MW, Noordzij M, Tomson C, Couchoud C, Cancarini G, Ansell D, et al. Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis. 2012;60(6):940–8. doi: 10.1053/j.ajkd.2012.07.015.
6. Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012;7(5):782–94. doi: 10.2215/CJN.1060101.
7. Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney Int. Suppl. 2013;3:60–157. doi: 10.1038/kisup.2013.3.
8. Hassannia T, Farzadfar F, Noori A, Moradi-Lakeh M, Delavari F, Jamshidi HR. National and sub-national prevalence, trend, and burden of end stage renal diseases (ESRD) in Iran 1990-2013. Arch Iran Med. 2014;17(12):3–800.
9. Kudhair, Ahmed & Khalid, Hassan & Abdalruda, & Abdalruda, Khalid & Abdalruda, Khalid. The effect of dialysis on the psychological state of hospital entrance in the renal centers. International Journal of Clinical Biology andBiochemistry.2022;4:27-31. 10.33545/26646188.2022.v4.i1a.27.
10. Damico G. Comparability of the different registries on renal replacement therapy. Am J Kidney Dis. 1995;25:113–8. doi:10.1177/089686089901902S68.
11. Al-Hilali N, Al-Humoud HM, Ninan VT, Nampoory MR, Ali JH, Johny KV. Profiled hemodialysis reduces intradialytic symptoms. Transplant Proc. 2004;36(6):1827–8. doi: 10.1016/j.transproceed.2004.06.023.
12. Rayner HC, Larkina M, Wang M, Graham-Brown M, van der Veer SN, Ecder T, et al. International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017;12(12):2000–7. doi: 10.2215/CJN.03280317.
13. Agrawal RK, Khakurel S, Hada R, Shrestha D, Baral A. Acute intradialytic complications in end stage renal disease on maintenance hemodialysis. JNMA J Nepal Med Assoc. 2012;52(187):118–21. doi 10.31729/jnma.358.
14. Rizzo MA, Frediani F, Granata A, Ravasi B, Cusi D, Gallieni M. Neurological complications of hemodialysis: state of the art. J Nephrol. 2012;25(2):170–82. doi: 10.5301/jn.5000087.
15. Goudarzian AH, Sharif Nia H, Okamoto Y, Rhee C, McFarlane P, Nejad F. Adverse effects of hemodialysis on kidney patients: how good the evidence is. Int J Med Invest. 2015;4:357–61.
16. Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DJ, Peterson RA, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005;16(8):2487–94. doi: 10.1681/ASN.2005020157.
17. Ghahri Sarabi A, Torabi M, Abed Saeedi Z, Akbarzadeh Baghban A. Incidence of intradialytic complications and their risk factors in patients undergoing hemodialysis in hospitals affiliated with the Medical University of Hamadan Iran. Adv Nurs Midwifery. 2012;20(72):37–44. doi: 10.22037/SBMUANM.V21I72.2691.
18. Alyaseen F. The patient care and complications of hemodialysis procedure for renal failure patients: a descriptive study at al Nasiriya city, South of Iraq. J Glob Inf Manag. 2019;10:356–65.
19. Sakhuja V, Jha V, Ghosh AK, Ahmed S, Saha TK. Chronic renal failure in India. Nephrol Dial Transplant. 1994;9:871–2.
20. The burden of end-stage renal disease in Khartoum, Sudan: cost of illness study. J Med Econ. 2024;27(1):455–62. doi:10.1080/13696998.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.